Narrow search
Showing 1 - 10 of 2,227
Cover Image
Generic competition and price regulation in pharmaceuticals : evidence from the European Union
Tuncay, Berna - In: Dynamic optics in economics : quantitative, …, (pp. 221-240). 2020
Persistent link: https://www.econbiz.de/10013040759
Cover Image
Reference pricing systems on the pharmaceutical market
Unsorg, Maximiliane - In: German economic review : GER 23 (2022) 3, pp. 403-421
Persistent link: https://www.econbiz.de/10013384327
Cover Image
Competitive pricing within pharmaceutical classes : evidence on ‘‘follow-on’’ drugs in Germany 1993 - 2008
Mueller, Michael T.; Frenzel, Alexander - In: The European journal of health economics : HEPAC ; … 16 (2015) 1, pp. 73-82
Persistent link: https://www.econbiz.de/10011300287
Cover Image
An empirical model of drug pricing and competition : a dynamic perspective
Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193
Persistent link: https://www.econbiz.de/10010351165
Cover Image
EU enlargement, parallel trade and price competition in pharmaceuticals : has the price competition increased?
Granlund, David; Köksal-Ayhan, Miyase Yesim - In: The B.E. journal of economic analysis & policy 16 (2016) 2, pp. 1069-1092
Persistent link: https://www.econbiz.de/10011508040
Cover Image
The generics paradox revisited : empirical evidence from regulated markets
Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239
Persistent link: https://www.econbiz.de/10010345456
Cover Image
Pricing the pharmaceuticals when the ability to pay differs : taking vertical equity seriously
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - 2019
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012157261
Cover Image
Pricing the pharmaceuticals when the ability to pay differs
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - In: Journal of the Finnish Economic Association : JFEA 2 (2021) 1, pp. 25-48
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. This paper analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal third-degree price discrimination. First, the paper...
Persistent link: https://www.econbiz.de/10013286496
Cover Image
Pharmaceutical spending and early-stage innovation in EU countries
Kourouklis, Dimitrios; Gandjour, Afschin - In: Industry and innovation 29 (2022) 10, pp. 1141-1170
Persistent link: https://www.econbiz.de/10013493053
Cover Image
The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-Day exclusivity period
Olson, Luke M.; Wendling, Brett W. - 2013
Persistent link: https://www.econbiz.de/10010473653